MDVL

MedAvail Holdings, Inc [MDVL] Stock Forecast

Q: What is MedAvail Holdings, Inc stock symbol ?

MedAvail Holdings, Inc is a CA stock, located in Mississauga of On and trading under the symbol MDVL

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

MDVL Stock Summary

Earnings have grown 94.81% per last year.

EPS has been increasing for the past 3 years (Yearly statements)

In the last year, shareholders have seen their holdings diluted. Dilution over past year is 146.06%

Earnings are expected to fall -100% next year

EPS has been decreasing for the past 3 quarters (Quarter statements)

Does not have any significance market cap ($2.91M)

Profit margins (-1.95%) are lower than the previous year (-1.1%)

In the News

MDVL Financial details

Company Rating

Neutral

Market Cap

2.91M

Income

-46.48M

Revenue

23.84M

Book val./share

12.82

Cash/share

7.99

Dividend

Dividend %

Employees

279

Optionable

Shortable

Yes

Earnings

11 Apr 2024

P/E

-0.15

Forward P/E

PEG

-0.01

P/S

0.27

P/B

0.31

P/C

0.23

P/FCF

-0.2

Quick Ratio

3.53

Current Ratio

6.51

Debt / Equity

0.1

LT Debt / Equity

0.09

EPS (TTM)

-3.73

EPS next Y

EPS next Q

EPS this Y

-46.27%

EPS next Y

EPS next 5Y

EPS last 5Y

328.23%

Revenue last 5Y

160.41%

Revenue Q/Q

-34.68%

EPS Q/Q

1363.64%

SMA20

SMA50

-60%

SMA100

-60%

Inst Own

16.72%

Inst Trans

0.2%

ROA

-155%

ROE

-234%

ROC

-1.23%

Gross Margin

Oper. Margin

-133%

Profit Margin

-195%

Payout

Shs Outstand

Shs Float

Target Price

52W Range

1.31-20.9

52W High

-91%

52W Low

+80%

RSI

Rel Volume

1.83

Avg Volume

128.76K

Volume

236.13K

Perf Week

30.43%

Perf Month

-44.62%

Perf Quarter

Perf Half Y

-61.04%

Beta

-0.143

Volatility

0.17%, 0.68%

Prev Close

27.66%

Price

1.8

Change

27.66%

MDVL Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	0	0.12	2.44	0.68	0.66
Net income per share	0	-0.7	-4.57	-1.34	-0.72
Operating cash flow per share	0	-0.62	-5	-1.3	-0.72
Free cash flow per share	0	-0.63	-5.15	-1.4	-0.76
Cash per share	0	0.28	10.13	0.6	0.17
Book value per share	0	-3.05	10.67	0.58	0.32
Tangible book value per share	0	-3.05	10.63	0.51	0.31
Share holders equity per share	0	-3.05	10.67	0.58	0.32
Interest debt per share	0	0.45	0.82	0.39	0.13
Market cap	6082.69B	22.99B	4.31B	2.29B	986.65M
Enterprise value	6082.69B	23B	4.25B	2.28B	982.28M
P/E ratio	-1.89M	-1.03K	-164.75	-52.17	-20.72
Price to sales ratio	16.9M	6.1K	308.26	103.3	22.89
POCF ratio	-1.87M	-1.18K	-150.37	-53.76	-20.7
PFCF ratio	-1.87M	-1.15K	-146.2	-49.9	-19.75
P/B Ratio	2.16M	-237.9	70.51	119.85	47.38
PTB ratio	2.16M	-237.9	70.51	119.85	47.38
EV to sales	16.9M	6.1K	304.36	102.96	22.79
Enterprise value over EBITDA	-1.49M	-1.21K	-203.63	-52.71	-21.16
EV to operating cash flow	-1.87M	-1.18K	-148.47	-53.59	-20.61
EV to free cash flow	-1.87M	-1.15K	-144.35	-49.74	-19.66
Earnings yield	0	0	-0.01	-0.02	-0.05
Free cash flow yield	0	0	-0.01	-0.02	-0.05
Debt to equity	0	-0.14	0.06	0.64	0.34
Debt to assets	0	0.75	0.05	0.32	0.21
Net debt to EBITDA	0	-0.25	2.61	0.17	0.09
Current ratio	1.78	1.84	8.39	3.65	4.03
Interest coverage	255.06	-28.21	-16.77	-73.87	-39.61
Income quality	1.01	0.91	1.07	0.97	1
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	5.08	4.12	1.19	1.01	0.55
Research and developement to revenue	0	0.29	0.05	0.04	0.03
Intangibles to total assets	0.28	0	0	0.06	0.01
Capex to operating cash flow	0	0.02	0.03	0.08	0.05
Capex to revenue	0	-0.11	-0.06	-0.15	-0.05
Capex to depreciation	0	-0.24	-0.45	-1.28	-0.49
Stock based compensation to revenue	0.65	0.09	0.03	0.05	0.05
Graham number	0	6.95	33.12	4.2	2.27
ROIC	-1.07	0.26	-0.31	-1.28	-1.54
Return on tangible assets	-1	-1.24	-0.38	-1.22	-1.46
Graham Net	0	-3.26	9.13	0.11	0.06
Working capital	1.27M	6.41M	56.25M	19.88M	17.99M
Tangible asset value	1.58M	-96.72M	60.84M	16.77M	20.36M
Net current asset value	1.27M	-100.56M	55.6M	8.32M	11.62M
Invested capital	0	-0.14	0.06	0.64	0.34
Average receivables	41K	247K	968K	1.35M	1.7M
Average payables	206K	256.5K	808K	2.67M	2.84M
Average inventory	1.73M	3.14M	3.71M	3.37M	5.43M
Days sales outstanding	79.08	40.27	39.72	19.61	18.7
Days payables outstanding	347.34	35.81	55.51	67.05	15.09
Days of inventory on hand	2.47K	593.98	116.78	65.53	62.48
Receivables turnover	4.62	9.06	9.19	18.61	19.52
Payables turnover	1.05	10.19	6.58	5.44	24.19
Inventory turnover	0.15	0.61	3.13	5.57	5.84
ROE	-1.14	0.23	-0.43	-2.3	-2.29
Capex per share	0	-0.01	-0.14	-0.1	-0.04

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q2

Metric	2022-06-30	2022-09-30	2022-12-31	2023-03-31	2023-06-30
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	0.16	0.14	0.14	0.01	0.23
Net income per share	-0.17	-0.15	-0.14	-0.22	-3.22
Operating cash flow per share	-0.18	-0.14	-0.13	-0.06	-2.44
Free cash flow per share	-0.19	-0.15	-0.13	-0.07	-2.49
Cash per share	0.42	0.34	0.14	0.23	7.99
Book value per share	0.47	0.39	0.26	0.05	12.82
Tangible book value per share	0.43	0.37	0.25	0.05	12.45
Share holders equity per share	0.47	0.39	0.26	0.05	12.82
Interest debt per share	0.18	0.16	0.09	0.03	1.34
Market cap	5.31B	3.11B	1.2B	1.15B	22.03M
Enterprise value	5.29B	3.09B	1.2B	1.14B	9.93M
P/E ratio	-113.2	-64.06	-27.14	-16.46	-0.95
Price to sales ratio	474.41	270.99	105.87	1.86K	54.39
POCF ratio	-426.17	-268.46	-115.75	-221.09	-5.03
PFCF ratio	-398.21	-264.55	-111.33	-220.37	-4.93
P/B Ratio	161.83	99.21	57.7	276.3	0.96
PTB ratio	161.83	99.21	57.7	276.3	0.96
EV to sales	472.9	269.68	105.48	1.83K	24.53
Enterprise value over EBITDA	-463.21	-318.28	-111.44	-226.62	-2.47
EV to operating cash flow	-424.81	-267.16	-115.33	-217.92	-2.27
EV to free cash flow	-396.95	-263.27	-110.93	-217.21	-2.22
Earnings yield	0	0	-0.01	-0.02	-0.26
Free cash flow yield	0	0	-0.01	0	-0.2
Debt to equity	0.38	0.39	0.34	0.54	0.1
Debt to assets	0.23	0.25	0.21	0.06	0.08
Net debt to EBITDA	1.48	1.54	0.41	3.3	3.01
Current ratio	4.85	5.58	4.03	6.34	6.51
Interest coverage	-41.37	-36.48	-32.86	-29.65	-30.51
Income quality	1.06	0.98	0.94	0.3	0.76
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0.55	0.95	0.42	8	10.92
Research and developement to revenue	0.03	0.02	0.01	0.28	0.36
Intangibles to total assets	0.05	0.03	0.01	0.01	0.02
Capex to operating cash flow	0.07	0.01	0.04	0	0.02
Capex to revenue	-0.08	-0.01	-0.04	-0.03	-0.23
Capex to depreciation	-1.34	-0.1	-0.25	-0.02	-0.21
Stock based compensation to revenue	0.05	0.05	0.05	1	0.94
Graham number	1.34	1.15	0.9	0.5	30.47
ROIC	-0.24	-0.26	-0.36	-0.96	-0.18
Return on tangible assets	-0.23	-0.25	-0.34	-0.5	-0.2
Graham Net	0.19	0.17	0.05	-0.1	7.09
Working capital	32.5M	32.34M	17.99M	27.4M	22.89M
Tangible asset value	29.94M	29.73M	20.36M	3.74M	22.39M
Net current asset value	20.9M	20.85M	11.62M	986K	20.19M
Invested capital	0.38	0.39	0.34	0.54	0.1
Average receivables	1.91M	2.17M	2.24M	1.21M	249.5K
Average payables	1.44M	2.44M	1.84M	1.29M	847K
Average inventory	5.35M	6.01M	6.67M	7.82M	9.38M
Days sales outstanding	16.71	17.76	17.52	30.05	64.89
Days payables outstanding	25.19	17.75	13.14	222.64	315.59
Days of inventory on hand	49.27	56.65	54.4	2.16K	3.99K
Receivables turnover	5.39	5.07	5.14	3	1.39
Payables turnover	3.57	5.07	6.85	0.4	0.29
Inventory turnover	1.83	1.59	1.65	0.04	0.02
ROE	-0.36	-0.39	-0.53	-4.2	-0.25
Capex per share	-0.01	0	-0.01	0	-0.05

MDVL Frequently Asked Questions

What is MedAvail Holdings, Inc stock symbol ?

MedAvail Holdings, Inc is a CA stock , located in Mississauga of On and trading under the symbol MDVL

What is MedAvail Holdings, Inc stock quote today ?

MedAvail Holdings, Inc stock price is $1.8 today.

Is MedAvail Holdings, Inc stock public?

Yes, MedAvail Holdings, Inc is a publicly traded company.

Something similar

Top by Market Cap

Same Sector

Same Price Range

Similar Market Cap

Company Profile

Volume Average 128.76K
Market Capitalization 2.91M
Employee 279
CEO Emilia Keric
Headquarters Mississauga,ON,CA
IPO Date 2010-05-03
Website https://medavail.com

MedAvail Holdings, Inc., a technology-enabled retail pharmacy technology and services company, develops and commercializes self-service pharmacy, mobile application, kiosk, and drive-thru solutions in the United States and Canada. It operates in two segments, Retail Pharmacy Services and Pharmacy Technology. The company's MedCenter enables on-site pharmacy in medical clinics, retail store locations, employer sites with and without onsite clinics, and other location where onsite prescription dispensing is desired, as well as establishes an audio-visual connection to a live pharmacist enabling prescription drug dispensing to occur directly to a patient with real-time supervision by a pharmacist. It also owns and operates SpotRx, a retail pharmacy platform. As of December 31, 2021, the company had 81 MedCenter kiosks. MedAvail Holdings, Inc. is headquartered in Mississauga, Canada.